Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
Top Cited Papers
- 30 August 2004
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 19 (9) , 1020-1028
- https://doi.org/10.1002/mds.20213
Abstract
The Movement Disorder Society Task Force for Rating Scales for Parkinson's disease (PD) prepared a critique of the Hoehn and Yahr scale (HY). Strengths of the HY scale include its wide utilization and acceptance. Progressively higher stages correlate with neuroimaging studies of dopaminergic loss, and high correlations exist between the HY scale and some standardized scales of motor impairment, disability, and quality of life. Weaknesses include the scale's mixing of impairment and disability and its non‐linearity. Because the HY scale is weighted heavily toward postural instability as the primary index of disease severity, it does not capture completely impairments or disability from other motor features of PD and gives no information on nonmotor problems. Direct clinimetric testing of the HY scale has been very limited, but the scale fulfills at least some criteria for reliability and validity, especially for the midranges of the scale (Stages 2–4). Although a “modified HY scale” that includes 0.5 increments has been adopted widely, no clinimetric data are available on this adaptation. The Task Force recommends that: (1) the HY scale be used in its original form for demographic presentation of patient groups; (2) when the HY scale is used for group description, medians and ranges should be reported and analysis of changes should use nonparametric methods; (3) in research settings, the HY scale is useful primarily for defining inclusion/exclusion criteria; (4) to retain simplicity, clinicians should “rate what you see” and therefore incorporate comorbidities when assigning a HY stage; and (5) because of the wide usage of the modified HY scale with 0.5 increments, this adaptation warrants clinimetric testing. Without such testing, however, the original five‐point scales should be maintained. © 2004 Movement Disorder SocietyKeywords
This publication has 41 references indexed in Scilit:
- The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendationsMovement Disorders, 2003
- Systematic evaluation of rating scales for impairment and disability in Parkinson's diseaseMovement Disorders, 2002
- The EQ-5D---a generic quality of life measure---is a useful instrument to measure quality of life in patients with Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Patterns of Outcome Measurement in Parkinson’s Disease Clinical TrialsNeuroepidemiology, 2000
- The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index scoreAge and Ageing, 1997
- Interobserver reliability between neurologists in training of Parkinson's disease rating scales. A multicenter studyMovement Disorders, 1991
- Variable expression of Parkinson's diseaseNeurology, 1990
- Evaluating the evaluationsNeurology, 1983
- ParkinsonismNeurology, 1967
- A METHOD FOR EVALUATING DISABILITY IN PATIENTS WITH PARKINSONʼS DISEASEJournal of Nervous & Mental Disease, 1961